arrow
J

Juan R. Tejedo

instituto de salud carlos iii
H指数:20
被引数:1,069

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Non-Viral Therapy in COVID-19: Where Are We Standing? How Our Experience with COVID May Help Us Develop Cell Therapies for Long COVID Patients

非病毒疗法在COVID-19中的应用:我们目前处于什么位置?我们与COVID的经验如何帮助我们为长COVID患者开发细胞疗法

2025-08-210
PRE
Rationale for combined therapies in severe-to-critical COVID-19 patients
2023-09-111
OAAI
Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming

基于间充质基质细胞的疗法有望用于蛇咬伤后的肌肉再生

2021-02-038
OAAI
Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (vol 10, 1151, 2019)

2型糖尿病严重肢体缺血的成本有效,安全和个性化的细胞疗法 (第10卷,1151,2019)

2020-09-020
OAAI
Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus

2型糖尿病严重肢体缺血的成本有效,安全和个性化的细胞疗法

2019-06-0450
OAAI
Differentiation of Mouse Embryonic Stem Cells Toward Functional Pancreatic β-Cell Surrogates Through Epigenetic Regulation of Pdx1 by Nitric Oxide

一氧化氮通过Pdx1的表观遗传调控小鼠胚胎干细胞向功能性胰腺 β 细胞替代物的分化

2016-10-0112
OAAI
Nitric Oxide Prevents Mouse Embryonic Stem Cell Differentiation Through Regulation of Gene Expression, Cell Signaling, and Control of Cell Proliferation

一氧化氮通过调节基因表达,细胞信号传导和控制细胞增殖来阻止小鼠胚胎干细胞分化

2016-03-0816
PREAI